A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
Clinical trial NCT06633783 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06633783
- Sponsor
- Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2026-05-30
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.